Volcano’s Legal Win Removes Headline Risk and 3 Must-See Stock Analyses
Mag Silver Corporation (AMEX:MVG): Due to relative valuation, Canaccord removed Mag SilverCorporation from their Focus List.
Volcano Corporation (NASDAQ:VOLC): Leerink believes Volcano Corporation’s legal win Friday against St. Jude Medical (NYSE:STJ) presents a best-case scenario and removes a headline risk for the company. The firm reiterates an Outperform rating on shares of Volcano with a $32 price target.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Leerink raised their price target for Regeneron Pharmaceuticals, citing expectations for Eylea’s market penetration over the next year. Eylea treats wet age-related macular degeneration AMD , the leading cause of blindness in the elderly. The firm reiterated an Outperform rating on their stock.
Edwards Lifesciences Corp. (NYSE:EW): Leerink believes that Edwards Lifesciences Corp.’s third quarter results contained no surprises and that a strong fourth quarter is achievable. The firm continues to view the recent pullback in shares as a buying opportunity and reiterates an Outperform rating on Edwards Lifesciences. Credit Suisse lowered Edwards Lifesciences’s price target due to lowered TAVI and growth assumptions. Shares are Underperform rated.
Don’t Miss: 3 Tech Titans With Earnings You Must Know Now.